Selected research
Industry Research
Saliva Drug and Alcohol Testing Industry Research Report 2026
Market perspective
The global Saliva Drug and Alcohol Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Saliva Drug and Alcohol Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Saliva Drug and Alcohol Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Saliva Drug and Alcohol Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Saliva Drug and Alcohol Testing include Abbott, OraSure Technologies, Premier Biotech, Alcolizer, CareHealth America, AlphaBiolabs, AlcoDigital, VeriCheck and Azova, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Saliva Drug and Alcohol Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Saliva Drug and Alcohol Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Saliva Drug and Alcohol Testing Market by Company
Abbott
OraSure Technologies
Premier Biotech
Alcolizer
CareHealth America
AlphaBiolabs
AlcoDigital
VeriCheck
Azova
Draeger
Securetec Detektions-Systeme
Quest Diagnostics
Oranoxis
Salimetrics
Neogen Corporation
UCP Biosciences
Lin-Zhi International
MEDACX
AccuBioTech
Wondfo Biotech
Assure Tech
Express Medicals
Crystal Health
KINNECT
AusHealth
Dorevitch Pathology
Labcorp
Eurofins
Concentra
Bellin Health
Randox
MediNat
Clinical Labs
MHE
Awanui Labs
David Barber Occupational Health
SYNLAB
Test Smartly Labs
Cansford Laboratories
Medigold Health
PAM Group
Drugwise
Safework Health
Humanomics
CannAmm
Micro-Distributing
Saliva Drug and Alcohol Testing Segment by Type
On-Site Screening Products
Lab Testing
Saliva Drug and Alcohol Testing Segment by Application
Criminal Justice Testing
Workplace Testing
Rehabilitation Therapy
Others
Saliva Drug and Alcohol Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saliva Drug and Alcohol Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Saliva Drug and Alcohol Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saliva Drug and Alcohol Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Saliva Drug and Alcohol Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-Site Screening Products
- Lab Testing
Applications
- Criminal Justice Testing
- Workplace Testing
- Rehabilitation Therapy
- Others
Companies covered
- Abbott
- OraSure Technologies
- Premier Biotech
- Alcolizer
- CareHealth America
- AlphaBiolabs
- AlcoDigital
- VeriCheck
- Azova
- Draeger
- Securetec Detektions-Systeme
- Quest Diagnostics
- Oranoxis
- Salimetrics
- Neogen Corporation
- UCP Biosciences
- Lin-Zhi International
- MEDACX
- AccuBioTech
- Wondfo Biotech
- Assure Tech
- Express Medicals
- Crystal Health
- KINNECT
- AusHealth
- Dorevitch Pathology
- Labcorp
- Eurofins
- Concentra
- Bellin Health
- Randox
- MediNat
- Clinical Labs
- MHE
- Awanui Labs
- David Barber Occupational Health
- SYNLAB
- Test Smartly Labs
- Cansford Laboratories
- Medigold Health
- PAM Group
- Drugwise
- Safework Health
- Humanomics
- CannAmm
- Micro-Distributing
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Saliva Drug and Alcohol Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 On-Site Screening Products
- 2.2.3 Lab Testing
- 2.3 Saliva Drug and Alcohol Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Criminal Justice Testing
- 2.3.3 Workplace Testing
- 2.3.4 Rehabilitation Therapy
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Saliva Drug and Alcohol Testing Breakdown Data by Type
- 3.1 Global Saliva Drug and Alcohol Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Saliva Drug and Alcohol Testing Forecasted Market Size by Type (2027-2032)
4 Saliva Drug and Alcohol Testing Breakdown Data by Application
- 4.1 Global Saliva Drug and Alcohol Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Saliva Drug and Alcohol Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Saliva Drug and Alcohol Testing Market Perspective (2021-2032)
- 5.2 Global Saliva Drug and Alcohol Testing Growth Trends by Region
- 5.2.1 Global Saliva Drug and Alcohol Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Saliva Drug and Alcohol Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Saliva Drug and Alcohol Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Saliva Drug and Alcohol Testing Market Dynamics
- 5.3.1 Saliva Drug and Alcohol Testing Industry Trends
- 5.3.2 Saliva Drug and Alcohol Testing Market Drivers
- 5.3.3 Saliva Drug and Alcohol Testing Market Challenges
- 5.3.4 Saliva Drug and Alcohol Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Saliva Drug and Alcohol Testing Players by Revenue
- 6.1.1 Global Top Saliva Drug and Alcohol Testing Players by Revenue (2021-2026)
- 6.1.2 Global Saliva Drug and Alcohol Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Saliva Drug and Alcohol Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Saliva Drug and Alcohol Testing Head Office and Area Served
- 6.4 Global Saliva Drug and Alcohol Testing Players, Product Type & Application
- 6.5 Global Saliva Drug and Alcohol Testing Manufacturers Established Date
- 6.6 Global Saliva Drug and Alcohol Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 7.2 North America Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 7.4 North America Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 8.2 Europe Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 8.4 Europe Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 10.2 South America Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 10.4 South America Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Saliva Drug and Alcohol Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.1.4 Abbott Saliva Drug and Alcohol Testing Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 OraSure Technologies
- 12.2.1 OraSure Technologies Company Information
- 12.2.2 OraSure Technologies Business Overview
- 12.2.3 OraSure Technologies Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.2.4 OraSure Technologies Saliva Drug and Alcohol Testing Product Portfolio
- 12.2.5 OraSure Technologies Recent Developments
- 12.3 Premier Biotech
- 12.3.1 Premier Biotech Company Information
- 12.3.2 Premier Biotech Business Overview
- 12.3.3 Premier Biotech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.3.4 Premier Biotech Saliva Drug and Alcohol Testing Product Portfolio
- 12.3.5 Premier Biotech Recent Developments
- 12.4 Alcolizer
- 12.4.1 Alcolizer Company Information
- 12.4.2 Alcolizer Business Overview
- 12.4.3 Alcolizer Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.4.4 Alcolizer Saliva Drug and Alcohol Testing Product Portfolio
- 12.4.5 Alcolizer Recent Developments
- 12.5 CareHealth America
- 12.5.1 CareHealth America Company Information
- 12.5.2 CareHealth America Business Overview
- 12.5.3 CareHealth America Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.5.4 CareHealth America Saliva Drug and Alcohol Testing Product Portfolio
- 12.5.5 CareHealth America Recent Developments
- 12.6 AlphaBiolabs
- 12.6.1 AlphaBiolabs Company Information
- 12.6.2 AlphaBiolabs Business Overview
- 12.6.3 AlphaBiolabs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.6.4 AlphaBiolabs Saliva Drug and Alcohol Testing Product Portfolio
- 12.6.5 AlphaBiolabs Recent Developments
- 12.7 AlcoDigital
- 12.7.1 AlcoDigital Company Information
- 12.7.2 AlcoDigital Business Overview
- 12.7.3 AlcoDigital Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.7.4 AlcoDigital Saliva Drug and Alcohol Testing Product Portfolio
- 12.7.5 AlcoDigital Recent Developments
- 12.8 VeriCheck
- 12.8.1 VeriCheck Company Information
- 12.8.2 VeriCheck Business Overview
- 12.8.3 VeriCheck Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.8.4 VeriCheck Saliva Drug and Alcohol Testing Product Portfolio
- 12.8.5 VeriCheck Recent Developments
- 12.9 Azova
- 12.9.1 Azova Company Information
- 12.9.2 Azova Business Overview
- 12.9.3 Azova Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.9.4 Azova Saliva Drug and Alcohol Testing Product Portfolio
- 12.9.5 Azova Recent Developments
- 12.10 Draeger
- 12.10.1 Draeger Company Information
- 12.10.2 Draeger Business Overview
- 12.10.3 Draeger Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.10.4 Draeger Saliva Drug and Alcohol Testing Product Portfolio
- 12.10.5 Draeger Recent Developments
- 12.11 Securetec Detektions-Systeme
- 12.11.1 Securetec Detektions-Systeme Company Information
- 12.11.2 Securetec Detektions-Systeme Business Overview
- 12.11.3 Securetec Detektions-Systeme Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.11.4 Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Product Portfolio
- 12.11.5 Securetec Detektions-Systeme Recent Developments
- 12.12 Quest Diagnostics
- 12.12.1 Quest Diagnostics Company Information
- 12.12.2 Quest Diagnostics Business Overview
- 12.12.3 Quest Diagnostics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.12.4 Quest Diagnostics Saliva Drug and Alcohol Testing Product Portfolio
- 12.12.5 Quest Diagnostics Recent Developments
- 12.13 Oranoxis
- 12.13.1 Oranoxis Company Information
- 12.13.2 Oranoxis Business Overview
- 12.13.3 Oranoxis Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.13.4 Oranoxis Saliva Drug and Alcohol Testing Product Portfolio
- 12.13.5 Oranoxis Recent Developments
- 12.14 Salimetrics
- 12.14.1 Salimetrics Company Information
- 12.14.2 Salimetrics Business Overview
- 12.14.3 Salimetrics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.14.4 Salimetrics Saliva Drug and Alcohol Testing Product Portfolio
- 12.14.5 Salimetrics Recent Developments
- 12.15 Neogen Corporation
- 12.15.1 Neogen Corporation Company Information
- 12.15.2 Neogen Corporation Business Overview
- 12.15.3 Neogen Corporation Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.15.4 Neogen Corporation Saliva Drug and Alcohol Testing Product Portfolio
- 12.15.5 Neogen Corporation Recent Developments
- 12.16 UCP Biosciences
- 12.16.1 UCP Biosciences Company Information
- 12.16.2 UCP Biosciences Business Overview
- 12.16.3 UCP Biosciences Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.16.4 UCP Biosciences Saliva Drug and Alcohol Testing Product Portfolio
- 12.16.5 UCP Biosciences Recent Developments
- 12.17 Lin-Zhi International
- 12.17.1 Lin-Zhi International Company Information
- 12.17.2 Lin-Zhi International Business Overview
- 12.17.3 Lin-Zhi International Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.17.4 Lin-Zhi International Saliva Drug and Alcohol Testing Product Portfolio
- 12.17.5 Lin-Zhi International Recent Developments
- 12.18 MEDACX
- 12.18.1 MEDACX Company Information
- 12.18.2 MEDACX Business Overview
- 12.18.3 MEDACX Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.18.4 MEDACX Saliva Drug and Alcohol Testing Product Portfolio
- 12.18.5 MEDACX Recent Developments
- 12.19 AccuBioTech
- 12.19.1 AccuBioTech Company Information
- 12.19.2 AccuBioTech Business Overview
- 12.19.3 AccuBioTech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.19.4 AccuBioTech Saliva Drug and Alcohol Testing Product Portfolio
- 12.19.5 AccuBioTech Recent Developments
- 12.20 Wondfo Biotech
- 12.20.1 Wondfo Biotech Company Information
- 12.20.2 Wondfo Biotech Business Overview
- 12.20.3 Wondfo Biotech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.20.4 Wondfo Biotech Saliva Drug and Alcohol Testing Product Portfolio
- 12.20.5 Wondfo Biotech Recent Developments
- 12.21 Assure Tech
- 12.21.1 Assure Tech Company Information
- 12.21.2 Assure Tech Business Overview
- 12.21.3 Assure Tech Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.21.4 Assure Tech Saliva Drug and Alcohol Testing Product Portfolio
- 12.21.5 Assure Tech Recent Developments
- 12.22 Express Medicals
- 12.22.1 Express Medicals Company Information
- 12.22.2 Express Medicals Business Overview
- 12.22.3 Express Medicals Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.22.4 Express Medicals Saliva Drug and Alcohol Testing Product Portfolio
- 12.22.5 Express Medicals Recent Developments
- 12.23 Crystal Health
- 12.23.1 Crystal Health Company Information
- 12.23.2 Crystal Health Business Overview
- 12.23.3 Crystal Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.23.4 Crystal Health Saliva Drug and Alcohol Testing Product Portfolio
- 12.23.5 Crystal Health Recent Developments
- 12.24 KINNECT
- 12.24.1 KINNECT Company Information
- 12.24.2 KINNECT Business Overview
- 12.24.3 KINNECT Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.24.4 KINNECT Saliva Drug and Alcohol Testing Product Portfolio
- 12.24.5 KINNECT Recent Developments
- 12.25 AusHealth
- 12.25.1 AusHealth Company Information
- 12.25.2 AusHealth Business Overview
- 12.25.3 AusHealth Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.25.4 AusHealth Saliva Drug and Alcohol Testing Product Portfolio
- 12.25.5 AusHealth Recent Developments
- 12.26 Dorevitch Pathology
- 12.26.1 Dorevitch Pathology Company Information
- 12.26.2 Dorevitch Pathology Business Overview
- 12.26.3 Dorevitch Pathology Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.26.4 Dorevitch Pathology Saliva Drug and Alcohol Testing Product Portfolio
- 12.26.5 Dorevitch Pathology Recent Developments
- 12.27 Labcorp
- 12.27.1 Labcorp Company Information
- 12.27.2 Labcorp Business Overview
- 12.27.3 Labcorp Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.27.4 Labcorp Saliva Drug and Alcohol Testing Product Portfolio
- 12.27.5 Labcorp Recent Developments
- 12.28 Eurofins
- 12.28.1 Eurofins Company Information
- 12.28.2 Eurofins Business Overview
- 12.28.3 Eurofins Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.28.4 Eurofins Saliva Drug and Alcohol Testing Product Portfolio
- 12.28.5 Eurofins Recent Developments
- 12.29 Concentra
- 12.29.1 Concentra Company Information
- 12.29.2 Concentra Business Overview
- 12.29.3 Concentra Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.29.4 Concentra Saliva Drug and Alcohol Testing Product Portfolio
- 12.29.5 Concentra Recent Developments
- 12.30 Bellin Health
- 12.30.1 Bellin Health Company Information
- 12.30.2 Bellin Health Business Overview
- 12.30.3 Bellin Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.30.4 Bellin Health Saliva Drug and Alcohol Testing Product Portfolio
- 12.30.5 Bellin Health Recent Developments
- 12.31 Randox
- 12.31.1 Randox Company Information
- 12.31.2 Randox Business Overview
- 12.31.3 Randox Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.31.4 Randox Saliva Drug and Alcohol Testing Product Portfolio
- 12.31.5 Randox Recent Developments
- 12.32 MediNat
- 12.32.1 MediNat Company Information
- 12.32.2 MediNat Business Overview
- 12.32.3 MediNat Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.32.4 MediNat Saliva Drug and Alcohol Testing Product Portfolio
- 12.32.5 MediNat Recent Developments
- 12.33 Clinical Labs
- 12.33.1 Clinical Labs Company Information
- 12.33.2 Clinical Labs Business Overview
- 12.33.3 Clinical Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.33.4 Clinical Labs Saliva Drug and Alcohol Testing Product Portfolio
- 12.33.5 Clinical Labs Recent Developments
- 12.34 MHE
- 12.34.1 MHE Company Information
- 12.34.2 MHE Business Overview
- 12.34.3 MHE Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.34.4 MHE Saliva Drug and Alcohol Testing Product Portfolio
- 12.34.5 MHE Recent Developments
- 12.35 Awanui Labs
- 12.35.1 Awanui Labs Company Information
- 12.35.2 Awanui Labs Business Overview
- 12.35.3 Awanui Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.35.4 Awanui Labs Saliva Drug and Alcohol Testing Product Portfolio
- 12.35.5 Awanui Labs Recent Developments
- 12.36 David Barber Occupational Health
- 12.36.1 David Barber Occupational Health Company Information
- 12.36.2 David Barber Occupational Health Business Overview
- 12.36.3 David Barber Occupational Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.36.4 David Barber Occupational Health Saliva Drug and Alcohol Testing Product Portfolio
- 12.36.5 David Barber Occupational Health Recent Developments
- 12.37 SYNLAB
- 12.37.1 SYNLAB Company Information
- 12.37.2 SYNLAB Business Overview
- 12.37.3 SYNLAB Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.37.4 SYNLAB Saliva Drug and Alcohol Testing Product Portfolio
- 12.37.5 SYNLAB Recent Developments
- 12.38 Test Smartly Labs
- 12.38.1 Test Smartly Labs Company Information
- 12.38.2 Test Smartly Labs Business Overview
- 12.38.3 Test Smartly Labs Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.38.4 Test Smartly Labs Saliva Drug and Alcohol Testing Product Portfolio
- 12.38.5 Test Smartly Labs Recent Developments
- 12.39 Cansford Laboratories
- 12.39.1 Cansford Laboratories Company Information
- 12.39.2 Cansford Laboratories Business Overview
- 12.39.3 Cansford Laboratories Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.39.4 Cansford Laboratories Saliva Drug and Alcohol Testing Product Portfolio
- 12.39.5 Cansford Laboratories Recent Developments
- 12.40 Medigold Health
- 12.40.1 Medigold Health Company Information
- 12.40.2 Medigold Health Business Overview
- 12.40.3 Medigold Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.40.4 Medigold Health Saliva Drug and Alcohol Testing Product Portfolio
- 12.40.5 Medigold Health Recent Developments
- 12.41 PAM Group
- 12.41.1 PAM Group Company Information
- 12.41.2 PAM Group Business Overview
- 12.41.3 PAM Group Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.41.4 PAM Group Saliva Drug and Alcohol Testing Product Portfolio
- 12.41.5 PAM Group Recent Developments
- 12.42 Drugwise
- 12.42.1 Drugwise Company Information
- 12.42.2 Drugwise Business Overview
- 12.42.3 Drugwise Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.42.4 Drugwise Saliva Drug and Alcohol Testing Product Portfolio
- 12.42.5 Drugwise Recent Developments
- 12.43 Safework Health
- 12.43.1 Safework Health Company Information
- 12.43.2 Safework Health Business Overview
- 12.43.3 Safework Health Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.43.4 Safework Health Saliva Drug and Alcohol Testing Product Portfolio
- 12.43.5 Safework Health Recent Developments
- 12.44 Humanomics
- 12.44.1 Humanomics Company Information
- 12.44.2 Humanomics Business Overview
- 12.44.3 Humanomics Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.44.4 Humanomics Saliva Drug and Alcohol Testing Product Portfolio
- 12.44.5 Humanomics Recent Developments
- 12.45 CannAmm
- 12.45.1 CannAmm Company Information
- 12.45.2 CannAmm Business Overview
- 12.45.3 CannAmm Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.45.4 CannAmm Saliva Drug and Alcohol Testing Product Portfolio
- 12.45.5 CannAmm Recent Developments
- 12.46 Micro-Distributing
- 12.46.1 Micro-Distributing Company Information
- 12.46.2 Micro-Distributing Business Overview
- 12.46.3 Micro-Distributing Revenue in Saliva Drug and Alcohol Testing Business (2021-2026)
- 12.46.4 Micro-Distributing Saliva Drug and Alcohol Testing Product Portfolio
- 12.46.5 Micro-Distributing Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst